Showing 1,381 - 1,400 results of 100,107 for search '(( 12 teer decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.44s Refine Results
  1. 1381
  2. 1382
  3. 1383
  4. 1384
  5. 1385
  6. 1386
  7. 1387
  8. 1388
  9. 1389
  10. 1390
  11. 1391
  12. 1392
  13. 1393
  14. 1394
  15. 1395
  16. 1396

    A tropomyosin point mutant recapitulates the <i>rng8/9</i> deletion phenotype. by Omaya Dudin (3926825)

    Published 2017
    “…(G) Kymographs of Myo52-tdTomato showing multiple stable dots over >60s in <i>cdc8</i><sup><i>E104A</i></sup> mutant. (H) Myo51-3YFP fluorescence at the fusion site is decreased in <i>cdc8</i><sup><i>E104A</i></sup> mutant (N = 15); (***) P < 3 × 10<sup>−5</sup>, t-test. …”
  17. 1397
  18. 1398

    Image_1_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

    Published 2021
    “…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”
  19. 1399

    Image_4_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

    Published 2021
    “…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”
  20. 1400

    Image_3_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

    Published 2021
    “…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”